Company Info
| Phone: | (866) 725-0930 |
| Year Established: | 2011 |
| Ticker: | ATHA |
| Exchange: | NASDAQ |
Contacts
| Primary: | Mark Litton, Ph.D., M.B.A. President & CEO |
| Other: | Andrew Gengos CFO & CBO Rachel Lenington, M.B.A. COO &vCDO Mark Worthington, JD General Counsel Kevin Church, PhD CSO Javier San Martin, M.D. CMO |
Company Description
Athira Pharma, formerly M3 Biotechnology, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration.
